Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Endocrine-Related Cancer|June 12, 2024
Genetic variants and down-regulation of CACNA1H in pheochromocytomaFredrika Svahn, Karolina Solhusløkk Höse, Adam Stenman, et al.
BMC Cancer|March 3, 2017
A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesisJoyce Y Cheng, Taylor C Brown, Timothy D Murtha, et al.
Oncogene|September 6, 2018
GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expressionXiaotian Yuan, Ninni Mu, Na Wang, et al.
Nucleic Acids Research|February 8, 2021
Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitorsYao Shi, Juan Yuan, Vilma Rraklli, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2019
EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistanceShuijie Li, Javier Rodriguez, Wenyu Li, et al.
Human Molecular Genetics|January 11, 2015
Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencingJohn W Kunstman, C Christofer Juhlin, Gerald Goh, et al.
Genes, Chromosomes & Cancer|June 3, 2015
Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated geneC Christofer Juhlin, Adam Stenman, Felix Haglund, et al.
The Journal of Clinical Endocrinology and Metabolism|December 10, 2014
Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinomaC Christofer Juhlin, Gerald Goh, James M Healy, et al.
JAMA Oncology|April 7, 2017
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed PreventionBirke Bausch, Francesca Schiavi, Ying Ni, et al.
Pageof 6